Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Pancreatic cancer
Closed
Phase 3
This trial is looking at gemcitabine on its own or alongside another drug called capecitabine after surgery for cancer of the pancreas.
It is open to people with cancer where the pancreatic duct meets the bile duct, the ampulla of Vater. Cancer that starts there is called ampullary cancer.
People who had ductal adenocarcinoma (cancer of the pancreas) were also able to join. But the trial team is no longer recuiting these people.
Cancer Research UK supports this trial.
Recruitment start: 13 October 2008
Recruitment end: 5 December 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Paula Ghaneh
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Royal Liverpool and Broadgreen University Hospital NHS Trust
University of Liverpool
This is Cancer Research UK trial number CRUK/07/024.
Last reviewed: 17 November 2022
CRUK internal database number: 636
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
